Search
for

    Glossary Calcipotriol

    synthetic vitamin D derivative used to treat psoriasis

    Calcipotriol, also known as calcipotriene, is a synthetic derivative of vitamin D used primarily in the treatment of psoriasis. It works by slowing down the growth of skin cells, thereby reducing the scaling and thickness of psoriatic plaques.

    Related Terms

    Sort by

    Research 30 of 676

    1. Reduction of Intrafollicular Apoptosis in Chemotherapy-Induced Alopecia by Topical Calcitriol-Analogs 1998 · 53 citations
    2. Successful Treatment of Alopecia Areata with Topical Calcipotriol 2012 · 51 citations
    3. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study. PubMed · 2015 · 38 citations
    4. Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo Journal of Cosmetic Dermatology · 2018 · 18 citations
    5. Topical Calcipotriol for Preventive Treatment of Hypertrophic Scars Archives of Dermatology · 2009 · 18 citations
    6. A case of peeling skin syndrome successfully treated with topical calcipotriol The Journal of Dermatology · 2006 · 16 citations
    7. Calcipotriol (Dovonex) scalp solution in the treatment of scalp psoriasis: comparative efficacy with 1% coal tar/1% coconut oil/0.5% salicylic acid (Capasal) shampoo, and long-term experience Journal of dermatological treatment · 2000 · 16 citations
    8. Systematized Epidermal Nevus with Epidermolytic Hyperkeratosis Improving with Topical Calcipotriol/Betametasone Dipropionate Combination Ointment Pediatric Dermatology · 2012 · 12 citations
    9. Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study Dermatology and therapy · 2020 · 10 citations
    10. Effects of 1?,25-dihydroxy-vitamin D3 and calcipotriol on organotypic cultures of outer root sheath cells: a potential model to evaluate antipsoriatic drugs Archives of dermatological research · 1993 · 10 citations
    11. Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis Clinical Cosmetic and Investigational Dermatology · 2019 · 9 citations
    12. Comparative study of efficacy of topical mometasone with calcipotriol versus mometasone alone in the treatment of alopecia areata International Journal of Trichology · 2019 · 9 citations
    13. The hair root pattern after calcipotriol treatment for scalp psoriasis. Acta Dermato Venereologica · 1995 · 8 citations
    14. Efficacy of topical calcipotriol betamethasone dipropionate as a new adjuvant therapy to follicular unit extraction technique in treatment of stable vitiligo: clinical, dermoscopic and immunohistological study Journal of Cosmetic Dermatology · 2021 · 6 citations
    15. Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata JAAD case reports · 2019 · 6 citations
    16. A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation Journal of dermatological science · 2017 · 5 citations
    17. Development of Fast Reverse Phase Liquid Chromatographic Method for Simultaneous Analysis of Betamethasone Dipropionate and Calcipotriol in Ointments and Bulk Drug Asian Journal of Chemistry · 2014 · 5 citations
    18. Topical use of calcipotriol does not potentiate squaric acid dibutylester effectiveness in the treatment of alopecia areata Journal of Dermatological Treatment · 1995 · 5 citations
    19. Topical Calcipotriol versus oral vitamin D in the treatment of alopecia areata 2019 · 3 citations
    20. A comparative study of Fractional co2 laser combined with topical methotrexate versus Fractional co2 laser combined with topical [Calcipotriol + Betamethasone] in the treatment of nail psoriasis QJM · 2021 · 2 citations
    21. Comparative efficacy of topical calcipotriol and tacrolimus in alopecia areata: A prospective trial Journal of Pakistan Association of Dermatologists · 2024 · 1 citations
    22. Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study Journal of cosmetic dermatology · 2022 · 1 citations
    23. Comparative Evaluation of Efficacy Between Topical Calcipotriol Used Along With Topical Clobetasol And Topical Clobetasol Monotherapy In Treatment Of Alopecia Areata: A Randomised Clinical Trial Journal of clinical and diagnostic research · 2021 · 1 citations
    24. Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis Expert Review of Dermatology · 2009 · 1 citations
    25. Efficacy of Calcipotriol/Betamethasone Ointment in the Management of Pediatric Alopecia Areata Annals of Dermatology · 2026
    26. Comparative Efficacy of Topical Calcipotriol, Intralesional Autologous Platelet-Rich Plasma Injection, and Combined Topical Calcipotriol with Intralesional Autologous Platelet-Rich Plasma Injection on Patients with Alopecia Areata Journal of Skin and Stem Cell · 2025
    27. Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study Indian Dermatology Online Journal · 2025
    28. Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide Monotherapy in Scalp and Beard Alopecia Areata: Results From a Randomized Single-Blinded Clinical Trial Journal of Cutaneous Medicine and Surgery · 2025
    29. Alopecia Areata and Vitamin D3 Deficiency: The Potential of Calcipotriol as a Treatment SKIN The Journal of Cutaneous Medicine · 2025
    30. Comparative efficacy of topical calcipotriol and tacrolimus in alopecia areata: A prospective trial Journal of Pakistan Association of Dermatologists · 2024